fbpx

Clinical Studies

Colonoscopy Research Studies

With more than 1.9 million new colorectal cancer (CRC) cases and 935,173 deaths, CRC is the 3rd most common cancer in men and 2nd most common cancer in women. It is also 2nd leading cause of cancer deaths for men and women in the U.S.

Charter Research partners with people just like you to enhance the lives of our friends, neighbors, and future generations.

Schedule a Prescreen

Your contact information

Do you live in Central Florida?

Preferred Charter Research location

I would like to receive the Charter Research newsletter.

Comments (not required)

This field is for validation purposes and should be left unchanged.

Types of Studies

What studies are available?

Below you’ll find the clinical trials that we’re currently enrolling patients in or will be soon.

View All Open Studies

Colorectal Cancer Blood Test
We are validating Signal-C®, a blood-based diagnostic test to screen for colorectal cancer, in hopes this innovative new test may one day indicate if you need further evaluation.

Commitment to Your Care

Who will I be working with?

Participating in a clinical trial can feel intimidating at first. Put your mind at ease by getting to know some of our caring experts who’ll be working with you every step of the way.

Learn more about our Commitment to Care

Our Promise to You

What resources do you have for me?

We regularly share insights, tips, and new discoveries to provide you the latest on the diseases and chronic conditions you’re living with.

See all resources